Aim: To determine safety and anti-herpes activity of selected medicinal plants cited by Community Health Workers in Mukhwa sub-location, Bukaya location in Kakamega County, Kenya. Study Design: Ethno-medical interview for selection of medicinal plants and In-vitro experiment for determination of safety and anti-herpes activity. Methodology: Eight medicinal plants were selected for safety and determination of anti-herpes activity of water extracts using Vero cell and Human herpes Virus type 1. The metabolism of 3 -(4, 5-Dimethylthiazole -2-y) -2, 5-diphenyltetra-zolium bromide (MTT) was used for cytotoxicity and different levels of extract antiviral experiments. End point titration technique (EPTT) was used for virus quantification and antiviral screening test.
INTRODUCTION AND BACKGROUND INFORMATION
Kakamega County is one of the 47 counties in the Republic of Kenya. It is located to the western side of the country, bordering Vihiga, Siaya, Bungoma, and Nandi counties. It covers an area of 3050.3 km 2 and has an altitude between 1,240 meters and 2000meters above sea level [1] . According to Kenya National AIDS Control program [2] , the HIV prevalence estimate was 5.9% by 2012, being generally the same as the national average of 6%. The cited priority service areas on HIV included strengthening of linkage to care for individuals testing positive, thus addressing the statistic showing that only 37.4% were linked to the services [3] . Further, the report indicated that the proportion of eligible clients started on ART was 81%, meaning that about 19% were either seeking care to nonreporting facilities or using self-administered care, with possibility of taking traditional medicine. Although statistics on HIV deaths for the county was not indicated, the national statistic of 5% [4] points to gaps in HIV care. Previous studies elsewhere have indicated a need for improved care for People living with HIV (PLwHIV), with reports indicating emergence of resistant HIV strains [5] , unsustainable donor driven free public sector provision of Antiretroviral treatments (ART), inhibited access to treatment due to factors such as lack of confidentiality, lack of transport to hospitals, shortage of health workers, long queues, and lack of adherence due to adverse drug reactions [6, 7] . Some HIV patients resort to use of ethnomedicinal plants as an alternative or concomitant use with ARTs in an attempt to overcome these challenges [8] .
Medicinal plants have been cited as key ingredient of medication therapy in traditional medicine [9] . In its report, the International Bioethics Committee (IBC) of UNESCO highlights issues of uncertain benefits and risks associated with the use. On the other hand, studies on medicinal plants selected from the community have shown that the materials have potential to solve human health challenges. For instance, HSV has been shown to respond very well to plant species such as Euphorbia continifolia, Euphorbia tirucali [10] and Carrisa edulis [11] . However, the health value of the majority of the medicines are still mainly anecdotal and the utilization seem to be increasing and dynamic, fueled by problems of HIV and other chronic conditions [6, 8] .
The group of viruses referred to as Herpes belong to the family, Herpesviridae. They are morphologically identical and biologically closely similar. Their replication in the nucleus results in inflammatory response and destruction of host cells [12] . The agents are host specific and establish lifelong latent infection, with occasional reactivation. Infection sometimes results in malignant forms of host cells [13] . Viruses within the family includes Varicella zoster Virus (VZV), Epstein -Barr virus (EBV), Human cytomegalovirus (HCMV), HSV and Human herpes viruses [14] . Herpes Simplex Viruses are classified in the sub family Alphaherpesvirinae together with VZV. The subfamily characteristics include relative rapid replication cycle In vitro, ability to establish lifelong infection in the sensory ganglia of the host and variable host range. Herpes Simplex virus type 1 and 2 vary in their clinical manifestation, but in both cases, symptomatic infections are characterized by painful vesicular or ulcerative lesions at various mucocutaneous sites [15] . Immunocompromised patients and infected neonates suffer severe complications due to extensive local disease, visceral involvement, general dissemination and or encephalitis [12] . Most immunocompetent individuals experience subclinical infections with either HSV-1 or HSV-2, mainly following reactivation of latent virus and subsequent mucocutaneous replication [14] . Infections may sometimes occur without symptoms and this usually lead to asymptomatic virus shedding, which is significant for oral HSV-I transmission among children, sexually transmitted HSV in adults and mother to child transmission during birth [16] . Acyclovir resistant strains are much less virulent in immune-competent individuals but cause serious and persistent symptoms in the immunocompromised [14] . Pharmaceutical studies have confirmed existence of active principles against several viruses in plants [17] but it is expected that further studies will discover more compounds since majority of plants have not been fully evaluated.
Infection with Herpes viruses have long been associated with increasing the likelihood of HIV infection [18, 19] and is recognized as one of the HIV defining illness [20] . The most widely used anti-herpes treatment are the nucleoside analogs, most of which the viruses are resistant to due to development of thymidine deficient strains. Medicinal plants seem to be a possible source of alternative compounds with different mode of action. This study sought to select and evaluate medicinal plants, claimed to be useful for conditions resembling herpes lesions. The medicines were cited by Community Health Workers (CHW) providing care to PLwHIV in Mukhwa sub-location, Bukaya location, Kakamega County in Kenya. The objectives of the study were to determine the safe limits of extract use and to detect their antiviral activity against Human herpes virus type 1.
MATERIALS AND METHODS

Plant Selection, Collection and Authentication
The plants were cited by community health workers providing care to people living with HIV 
Preparation of Aqueous Extracts
Plant materials were harvested and dried at room temperature for 2 weeks. The dried material was grinded to form powder in electric grinding machine. Fifty grams of powdered material was soaked in 500 ml of distilled water and heated to 80°C for one hour. The extract was cooled to room temperature and filtered using cotton wool. The filtrate was then frozen using dry ice in acetone, freeze dried and kept at -20°C until required for use. For experiments, the freeze dried material was dissolved in phosphate buffered saline to make a stock concentration of 1000 µg/ml. Working concentrations were made from the stock.
Preparation of Cell and Virus Culture
A cryovial of Vero cell line, ATCC CCL 81 was obtained from viral hemorrhagic fever (VHF) research laboratory, of the Kenya Medical Research Institute (KEMRI). The vial was placed in a water bath at 37°C to thaw. The content was transferred into a 75 cm 2 cell culture flask containing 25 ml of Eagles minimum essential growth media (MEM) supplemented with 2 mM Lglutamine, 10% (v/v) fetal calf serum, 2.5% (v/v) of 7.5% (W/V) Sodium bicarbonate and 1% (v/v) of pen strep (10,000 I.U/ml penicillin combined with 10,000 µg/ml streptomycin). The seeded culture flask was incubated in a humidified environment at 37°C in a 5% CO 2 incubator until cell culture was about 90% confluent. The 75 cm 2 cell culture flask was used to prepare virus stock of herpes simplex type 1 (ATCC ® VR -1789 TM ) purchased from American Type culture collection (ATCC) as explained below;
The flask was emptied of growth media and 1 mL. vial of herpes simplex virus type 1, HSV 1 ATCC ® VR -1789 TM emptied into the flask. Virus inoculum was adsorbed on to the cell monolayer for 1 hour in 5% CO 2 incubator at 37°C. The inoculum was removed and 25 ml of maintenance media made of the same chemically defined constituents as for growth media except fetal calf serum, used at 2.5%. The virus culture was incubated at 37°C in 5% CO 2 incubator and the virus stock harvested after 48 hours when about 90% cytopathic effect (CPE) was observed on the monolayer.
The virus was harvested by 3 times freezing in -80°C freezer and thawing in 37°C water bath. The maintenance media containing the virus was then centrifuged at 3,000 rpm for 10minutes and the supernatant aliquoted in 1 ml cryovials and kept at -80°C. The stock titer was determined by endpoint titration technique (EPTT) as previously described by [10] .
One cryovial of the stock virus was removed from the freezer and immediately thawed in a water bath at 37°C. The EPTT was carried out in a 24 hour growth culture of Vero cells in a 96-well plate, previously seeded with 100 µl of 2 x 10 4 cells /ml. The growth media was removed from the wells and the cells infected in quadruplicates with 100 µl of each tenfold dilution of the virus suspension from 10 . The plate was incubated for 48 hours in 5% CO 2 at 37°C. The virus titer was calculated using spearman-karba formula [10] , based on the proportion of replicate virus dilutions showing above 75% cytopathic effect on the cells. The stock virus titer was found to be 10 -7 (The dilution of virus required to cause lysis of 50% of the inoculated cultures; TCID 50/0.1ml ).
Cytotoxicity Test
Cytotoxicity was tested by determining viability of Vero cells after exposure to graded concentration of extracts. The methods previously used by Bentancur et al. [10] and Jaime et al. [21] was used. The method is based on the metabolism of 3 -(4, 5-Dimethylthiazole -2-y) -2, 5-diphenyltetra-zolium bromide (MTT), converting the yellow solution of the dye to purple colour. The intensity of the purple colour is directly proportional to the viability of the cells and is determined using a spectrophotometer. Three different MTT experiments in triplicate wells of 96 well plate was carried out using Vero cells (ATCC CCL 81). Each 96 well plate was designed for 3 extracts. Vero cells were seeded at 2 x 10 4 cells per well in columns 1,2,4,5,7,8,10 and 11 in EMEM supplemented with 10% fetal calf serum, 1% penicillin/ Streptomycin, 1% glutamine and 2.5% of 7.5% (W/V) sodium bicarbonate solution. Wells in row 3, 6, 9 and 12 received only growth media to serve as test extract blank (tb) and cell control blank (ccb). The cells were grown in 5% Carbon dioxide at 37°C for 24 hours. The growth media was removed and replaced with 100 µl of maintenance media containing all the ingredients similar to growth media except fetal calf serum at 2.5%. A 100 µl of 1000 µg/ml of Plant extract was added to row H of 96 well plate and serial doubling dilutions carried out up to row C, representing 500, 250, 125, 62.5, 31.25, 15.625 µg/mL, leaving row B and A to serve as cell control (CC). Cells were incubated at 37°C for 48 hours. The wells were emptied of the media and 10 µl of MTT prepared at 5mg/ml in phosphate buffered saline added to all the wells, and incubated for 4 hours. The MTT was removed and 100 µL of dimethyl Sulphoxide (DMSO) added. The Optical density of the wells were read at 562 nm and the cell toxicity expressed as percentage cell viability at each extract concentration calculated as follows; 
Anti-herpes Activity Screening
End point titration (EPTT)
End point titration technique (EPTT) as previously used by Betancur et al. [10] was carried out to detect anti-Herpes activity at 100 µgm/ml. The 96 well plate was seeded with the same Vero cell strain (ATCC CCL 81) at same density as for cytotoxicity test and incubated in the same chemically defined growth media and condition for 24 hours.
A 100 µl of 100 µg/mL of extract in maintenance media was added to quadruplicate cell wells 1 hour before a tenfold dilutions of previously titrated virus was added at 100 µl per well. The 96 well plate virus culture was incubated for 48 hours in a humidified atmosphere at 37°C in a 5% CO 2 . Virus control (VC) consisting of maintenance media added 1 hour in quadruplicate wells before a tenfold dilution of previously titrated virus was added at 100 µl per well. Drug control (DC) was set up in the same way as extracts except that a 100 µL of acyclovir solution prepared at 5 µg/mL in phosphate buffered saline from the tablet was used instead of the extract. Cell control (CC) and extract/acyclovir cytotoxicity (CTC) controls were included in respective experiments, consisting of non-infected cells without extract/acyclovir and cells with extract/acyclovir respectively. The virus titer was calculated using spearman-karba formula as for the determination of stock virus titer. The antivirus activity was expressed as titer reduction factor (RF) by calculating the ratio of the VC titer over virus titer in the presence of the extracts. The extracts were then evaluated for antiviral activity by MTT colorimetric technique at 100 µg/mL and 25 µg/mL to confirm antiviral activity and screen for graded response.
MTT Confirmation of antiviral response and screening for graded response
The method by Jaime et al. [21] was adopted. The selected extracts were screened for graded response at 100 µg/mL and 25 µg/mL using control virus (TCID 50 (0.1ml) = 1 x10 7 ) by MTT colorimetric assay. The 96-well plate was seeded as for EPTT assay and cells grown for 24 hours. The growth media was removed and cells pre-incubated in triplicates with 100 µl of extract at 100 µg/ml and 25 µg/ml for 1 hour. The extracts were replaced with 90 µl of control virus followed by 10 µl of extract concentration at 1000 and 250 µg/ml to make 100 µg/ml and 25 µg/ml respectively. Each test concentration had its own cytotoxicity control (CTC) containing test extract without the virus. Virus control (VC) and cell control (CC) was included in the experiments. The VC contained the virus without test extract while CC contained maintenance media without the virus or extract. Acyclovir at 5 µgl/ml was used as reference drug and treated the same way as test extract. For each of the wells containing cells; test extract at 25 µg/mL, test extract at 100 µg/mL, CC and VC, a blank well containing respective solutions without cells were included.
The wells were treated for spectrophotometric analysis by MTT procedure as explained for the cytotoxicity test. The antiviral activity was expressed in terms of percentage cell protection and calculated using the formula below;
ODt = Optical density of test extract, ODtb = Optical density of test blank, ODvc = Optical density of virus control, ODvcb = Optical density of virus control blank, ODcc = Optical density of cell control and ODccb= Optical density of cell control blank.
Determination of Inhibitory concentration 50 (IC 50 ) and therapeutic index
For extract giving more than 50% cell protection at both 25 and 100 µg/ml, inhibitory concentration 50 was determined. Growth media was removed from a 24 hour monolayer of Vero cells and replaced with extracts in duplicates at a final concentration of 500, 250, 125, 62.5, 31.25, 15.625 µg/mL with their respective CTC, blanks, CC and VC included and treated as explained above. The respective % cell protection was calculated and the IC 50 obtained by plotting a graph relating mean percentage protection of 3 different experiments and extract concentration. Therapeutic index (ie selective index) was expressed as the ratio of CC 50 /IC 50 . Stem Bark.
RESULTS AND DISCUSSION
Herpes zoster
Decoction and drinking
Isomanniflavanone; an ent-eriodictyol-(3a→6)-dihydroquercetin-linked biflavanone, 1,5-dimethoxyajacareubin; depsidone garcinisidone -G; (2"R,3"R)-preussiannon; euxanthone; 2-isoprenyl-1,3,5,6-tetrahydroxyxanthone; jacareubin; isogarcinol and garcinol [28] In vitro inhibition of gastrointestinal motility [29] Kk05 Cell viability experiments was aimed at detecting the limits beyond which the materials could cause harm to people using them, and also to detect the concentration that would allow the study of antiviral effect while minimizing toxicity. Except for S. pinnata, Table 2 indicates that most of the extracts preserved the viability of cells above 50% at 125 µg/ml but most of them had very limited or no none toxic range, thus Figs. 1-3 The results of EPTT screening (Table 3) indicate that extract from S. pinata, E. Abyssinica, P. alba and C. decapetala provided at least 10 1 fold protection of cells against viral infection.
In vitro Antiviral Activity by EPTT
However, further screening test by MTT at 100 and 25 µg/mL (Table 4) fold RF by EPTT indicates that the antiviral activity observed by EPTT could be due to its toxicity or the extract contains both toxic and antiviral principles. The toxicity affected MTT metabolism without causing immediate death or change in morphology as based on EPTT determination. The same explanation applies to P. alba, showing above 10 1 RF and only 5 and 6.9% cell protection at 25 and 100 µg/mL extract concentration respectively. Both V. adoensis is and G. buchananii gave a near 10 1 RF at 100 µg/mL showing 10 0.86 and 10 0.71 for V. adoensis and G. buchananii respectively. However, G. buchananii gave strong cell protection value by MTT showing that there might be a different factor contributing to cell recovery from effect of virus activity. Since Vero cells are known to be alpha and beta interferon deficient [44] , factors involved in cell health such as antioxidant property of plant material might have played synergistic role augmenting the little antiviral property of the extract. showing that there is good cell resistance to the effect of the extract. This phenomenon is indicated in therapeutic index (TI) showing˃ 25. The TI compares well with the TI value established in acyclovir [45] , indicating that the extract could provide useful compounds, if fractionated and identified by bioactivity guided assays. Phytochemical studies has previously reported the presence of; Isomanniflavanone; an ent-eriodictyol-(3a→6)-dihydroquercetinlinked biflavanone, 1,5-dimethoxyajacareubin; depsidone garcinisidone -G; (2"R,3"R)-preussiannon; euxanthone; 2-isoprenyl-1,3,5,6-tetrahydroxyxanthone; jacareubin; isogarcinol and garcinol in ethanolic-aqueous extract of G. buchananii [28] . None of these compounds have previously been investigated for antiviral activity, but it is worth noting that phenolic groups comprising a significant proportion of ethanolicaqueous extract, such as caffeic acid, chrysoplenols, leuteolin have previously been associated with anti HSV activity [46] . Strong antioxidant activity has been demonstrated and associated with the reported compounds in a bioguided assay [28] , and this could possibly contribute to enhanced cell health and therefore better cell preservation.
C. decapetala
For C. decapetala, the maximum cell protection concentration was approximately 120 µg/ml and maximum non-toxic concentration of approximately 20 µg/ml. The TI was ˃6 and like G. buchananii, there was good cell tolerance as well as favorable comparison with TI of acyclovir [45] . Previous studies have shown that the main constituents of C. decapetala belong to terpenoid and flavonoids [42] . The terpenoid compound previously associated with anti HSV activity was tetrahydro-cannabinol and as with G. buchananii, chrysoplenols and leuteolin have shown activity against HSV [46] . Again as in the case of G. buchananii, C. decapetala,has high antioxidant activity [45] which could partly explain the enhanced cell viability. 
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